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HIV‐exposed and HIV‐uninfected (HEU) infants may be at increased risk of poor
health and growth outcomes. We characterized infant growth trajectories in a cohort
of HEU infants to identify factors associated with healthy growth. HIV‐positive
women participating in prevention of mother‐to‐child HIV transmission programmes
in Kigali, Rwanda, were followed until their infants were 2 years old. Infant anthropo-
metrics were regularly collected. Latent class analysis was used to categorize infant
growth trajectories. Multiple logistic regression was used to estimate the odds of
infants belonging to each growth trajectory class. On average, this population of
HEU infants had moderate linear growth faltering, but only modest faltering in
weight, resulting in mean weight‐for‐length z‐score (WLZ) above the World Health
Organization (WHO) median. Mean WLZ was 0.53, and mean length‐for‐age z‐score
(LAZ) was −1.14 over the first 2 years of life. We identified four unique WLZ trajec-
tories and seven trajectories in LAZ. Low neonatal weight‐for‐age and a high rate of
illness increased the likelihood that infants were in the lightest WLZ class. Shorter
mothers were more likely to have infants with linear growth faltering. Female infants
who were older at the end of exclusive breastfeeding were more likely to be in the
second tallest LAZ class. In conclusion, the current WHO recommendations of Option
B+ and extended breastfeeding may induce higher WLZ and lower LAZ early in
infancy. However, there is considerable heterogeneity in growth patterns that is
obscured by simply analysing average growth trends, necessitating the analysis of
growth in subpopulations.
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The number of HIV‐exposed and HIV‐uninfected (HEU) infants born in
Africa is increasing as the wider use of antiretroviral drugs limits
mother‐to‐child HIV transmission (Evans, Jones, & Prendergast,
2016; Filteau, 2009; Joint United Nations Programme on HIV/AIDS,
2013). There is already considerable evidence that HIV‐positive
women on antiretroviral therapy (ART) have higher risk of experienc-
ing adverse pregnancy outcomes than HIV‐negative women due towileyonlinelibrary.com/jbiological effects of the virus or drugs (Alemu, Yalew, Fantahun, &
Ashu, 2015; Makasa et al., 2007; Ndirangu, Newell, Bland, & Thorne,
2012; Neri et al., 2013; Sofeu et al., 2014). Their infants may also be
at additional risk of slow growth and increased morbidity and mortality
due to the biological impact of HIV and ART exposure and covarying
socio‐economic risk factors (Brennan et al., 2016; Filteau, Baisley,
Chisenga, Kasonka, & Gibson, 2011; Pierre et al., 2016; Slogrove,
2016). Less exposure to breast milk, increased rates of maternal illness
and death leading to reduced care, and lower socio‐economic status© 2019 John Wiley & Sons Ltdournal/mcn 1 of 10
Key messages
• Mean growth trajectories of these HIV‐exposed and
HIV‐uninfected infants show that they continue to
experience meaningfully lower LAZ and elevated WLZ
than the WHO standard. This pattern is not seen
among other infants in low‐resource settings.
• There is considerable heterogeneity in the growth
trajectories of HIV‐exposed and HIV‐uninfected infants
in Kigali, Rwanda.
• Characteristics present at birth, such as infant sex,
neonatal weight, and maternal height, are predictive of
the growth trajectories of these infants.
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HEU infants (Arikawa, Rollins, Newell, & Becquet, 2016; Conserve
et al., 2015; Evans et al., 2016; Filteau, 2009; Filteau et al., 2011; Kuhn
et al., 2005; Le Roux, Abrams, Nguen, & Myer, 2016; Nicholson,
Chisenga, Siame, Kasonka, & Filteau, 2015; Sugandhi et al., 2013).
However, further research is necessary to fully understand growth
patterns in this at risk population.
In 2012, the World Health Organization (WHO) recommended
Option B+: universal, lifelong ART for all HIV‐positive pregnant and
breastfeeding women. Option B+ was quickly adopted in Rwanda,
where it was implemented in 2013. Before Option B+ and the WHO
recommendation for continued breastfeeding of HEU infants, HEU
infants were at higher risk of impaired growth than their unexposed
counterparts (Evans et al., 2016; Lartey et al., 2014; Omoni et al.,
2017). The prevalence of risk factors for poor growth associated
with HIV is expected to decrease with the adoption of Option B+
and the WHO recommendation for continued breastfeeding among
HIV‐positive mothers in low‐resource settings (Evans et al., 2016;
WHO, 2016). Improved maternal health, increased ART use, and
breastfeeding have decreased mortality, morbidity, and undernutrition
in HEU infants (Le Roux et al., 2016). The difference in mortality rates
between HEU infants and unexposed infants decreased as ART
became more available (Brennan et al., 2016). Therefore, the differ-
ences in growth outcomes between HEU infants and unexposed
infants could further decrease with Option B+ and the recommenda-
tion for extended breastfeeding. However, there is, as yet, little under-
standing of the growth patterns or the factors driving the variability in
growth patterns of these infants under the current recommendations.
The objective of our study was to characterize the patterns of
change in weight‐for‐length z‐score (WLZ) and length‐for‐age z‐score
(LAZ) of HEU infants in Kigali, Rwanda, under current WHO recom-
mendations. We developed growth trajectories in WLZ and LAZ to
reflect the variation in growth patterns in this population of HEU
infants and attempt to identify maternal and infant characteristics that
predict which trajectory infants will follow. We hypothesized that
HEU infant growth outcomes are approaching expected values rela-
tive to the WHO growth standards (WHO, 2011). Furthermore, we
hypothesized that infant sex; neonatal weight‐for‐age z‐score (WAZ);
water source; frequency of illnesses; age at the end of exclusive
breastfeeding; and maternal height, parity, and education are associ-
ated with growth trajectories in these infants.2 | METHODS
2.1 | Recruitment and study sample
The Kabeho Study (Kigali Antiretroviral and Breastfeeding Assessment
for the Elimination of HIV) enrolled 608 HIV‐positive, pregnant/post‐
partum women participating in prevention of mother‐to‐child HIV
transmission programmes in selected high‐volume health facilities in
Kigali, Rwanda. Women were required to have documented HIV infec-
tion, plan on remaining in the Kigali area after delivery, and provide
informed consent. All women were enrolled in standard prevention
of mother‐to‐child transmission (PMTCT) programmes under OptionB+, which provides lifelong ART to all HIV‐positive pregnant or
breastfeeding women. PMTCT programmes have active tracking of
patients in the community to decrease loss to follow‐up and use
performance‐based financing to encourage health teams to support
adherence and provide suitable care. Prophylactic cotrimoxazole was
started at 6 weeks.2.2 | Study visits and data collection
Study visits were conducted during regularly scheduled follow‐up
visits for PMTCT at health facilities within 2 weeks of birth; at 6, 10,
and 14 weeks; monthly from 4 to 18 months; and at 21 and
24 months. Immunizations, growth monitoring, infant feeding counsel-
ling, maternal ART dispensing, and family planning were all standard
parts of these visits. Birthweight was measured by birth attendants
in the clinical settings where births took place. If recorded birthweight
was not available, we used measurements taken at first study visit as a
measure of neonatal weight. At each visit, trained nurses took dupli-
cate measures of infant length to the nearest centimetre using Shorr
boards and weight to the nearest 10 g using UNICEF scales. HIV test-
ing of the infants was conducted according to standard national
procedures for early infant diagnosis by HIV polymerase chain reac-
tion (PCR) or rapid HIV testing at 6 weeks, 9 months, 18 months,
and 24 months by the National Reference Laboratory using Roche
COBAS AmpliPrep/TaqMan (V2.0). Dried blood spots were also used
to determine the infants HIV status at birth and 24 months. Mothers
were asked to report whether the infant currently or since the last
visit had cough, fever, diarrhoea, or oral thrush and to provide details
on infant feeding including breastfeeding and feeding of all other
foods and liquids.2.3 | Power calculation
The minimum sample size necessary to estimate the proportion of
stunted infants was determined to be 608 mother–infant pairs under
an assumption of 23.5% stunting with a precision of 4.5% (nQuery
Advisor v 4.0; National Institute of Statistics, Ministry of Health, &
ICF International, 2015). Ethical approvals were obtained from the
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Research Committee, and the George Washington University Institu-
tional Review Board. The protocol is registered with the U.S. National
Institutes of Health at clinicaltrials.gov (NCT02295800).2.4 | Data analysis
The repeat measurements for infant length and weight were averaged
at each time point and converted to z‐scores using the WHO growth
standards (WHO, 2011). The WHO standard and z‐scores were used
instead of raw weight and length to account for age differences at
each study visit and for easy comparison with other studies that also
use this standard. These standards were specifically designed to mon-
itor trends in child growth and allow for international comparison (de
Onis & Blossner, 2003). They are meant to represent expected growth
of infants living under conditions that allow them to reach their full
genetic potential, including with mothers who breastfeed and do not
smoke (WHO, 2006). The use of this standard means that we are
comparing the growth of infants in this cohort with a worldwide ideal
for healthy growth rather than to other infants in the region. Stunting,
wasting, and underweight were defined using the −2 standard
deviation cut points.
Data analysis was conducted in R (R Core Team, 2013). Latent
class models used the lcmm package to identify characteristic infant
growth trajectories for WLZ and LAZ (Prost‐Lima, Phillips, Diakite, &
Liquet, 2017). Latent class growth mixture models allow for the exam-
ination of heterogeneity in patterns of longitudinal outcomes within a
population. They do not assume that all individuals within the sample
come from the same underlying population, so they can be used to
identify subpopulations that experience different patterns in longitudi-
nal outcomes. Therefore, this method is appropriate for our research
goal of identifying the variation in growth patterns that occurs within
this cohort. Other studies have used latent class growth mixture
modelling to identify subpopulations that grew similarly and then used
class membership as a predictor of disease risk (Hoekstra, Barbosa‐
Leiker, Koppes, & Twisk, 2011; Landa, Gross, Stuart, & Bauman,
2012; Rzehak et al., 2013). It is less common to use baseline character-
istics to predict latent class membership (Li, Goran, Kaur, Nollen, &
Ahluwalia, 2007; Mebrahtu, Feltbower, Petherick, & Parslow, 2015).
Nonetheless, the same theoretical framework applies. An additional
advantage of latent class analysis is that it does not require that all
infants have measurements at the same ages. Although study mea-
surements were collected at regularly scheduled follow‐up visits,
mothers were not always able to attend visits at the specified ages.
Our method allows for infants to be classified into trajectories even
if some measurements occurred at different ages or were missing.
The LAZ models used age and age2 terms for growth; however,
the WLZ models used age, age2, and age3 terms. The number of latent
classes was chosen to maximize the number of possible trajectories
while maintaining sufficient sample size within each class. A post hoc
analysis of variance was used to examine correlations between class
membership. Multinomial logistic regression was conducted in the
mlogit package to identify maternal and infant characteristics associ-
ated with class membership (Crossant, 2013).Two models were used to identify infant and maternal factors
associated with WLZ and LAZ class membership. The first model
included baseline (non‐time‐varying) characteristics: infant sex, mater-
nal education, maternal height, water source, and neonatal WAZ.
Water source was defined as a binary variable reflecting where the
infant's household got water (a tap or an open water source). Neonatal
WAZ was used instead of birthweight because birth measures took
place up to a week after delivery. The second model included infant
sex, maternal education, percent of observation periods during which
the infant experienced an illness (percent of illness periods), and age
at the end of exclusive breastfeeding. The percent of illness periods
was calculated by dividing the number of times the mother reported
at least one illness since the last visit by the total number of observa-
tions. Age at the end of exclusive breastfeeding was estimated as the
midpoint of the time period between the visit when the mother first
reported giving the infant food or water and the previous visit. Before
the introduction of foods or liquids, infants are considered to be exclu-
sively breastfed. These factors were chosen because they are known
to be associated with infant growth endpoints in unexposed popula-
tions. Because HEU infants experience somewhat different risk
factors than unexposed infants, known risk factors for poor growth
may not have the same effect in this population. We sought to show
that these variables were related, not only to endpoints but also to
the path or trajectory by which infants reach their growth endpoints
among HEU infants. These models were not combined so that factors
determined before the period over which growth trajectories are
characterized are separated from those known only after. Therefore,
the first model can be interpreted as factors likely to influence growth
trajectories, whereas the second reflects factors that may covary with,
influence, or be influenced by growth. Each variable was tested for sex
differences, and when appropriate, sex interactions were included in
multivariate analysis.3 | RESULTS
3.1 | Study population
Recruitment took place from April 2013 to January 2014, and 608
women were initially recruited into the study; however, 34 mothers
left the study before the 6‐week visit. In addition, there were seven
sets of twins, resulting in a total of 581 mother–infant pairs enrolled
in the study at 6 weeks (Gill et al., 2017). Growth trajectories could
be made for 578 infants included in final analysis; however, only 453
infants were retained through the entire 2 years of the study. During
the course of the study, 15 infants died and the remainder were lost
to follow‐up. Female infants represented 49% of the study population.
The majority of women had not completed primary school (56%).
Within 1 month of enrolment, all women were receiving ART.
Adherence to the ART regimen was high with less than 10% of women
reporting having missed one dose in the last 3 days at any of the study
visits. Mothers were generally in good health, with a mean body mass
index (BMI) of 25.5 at the end of the study. No women were
underweight. Only 6% of women had CD4 counts less than 200.












Change in z scores over time
FIGURE 1 Average anthropometric values for weight‐for‐length
z‐score (dotted), weight‐for‐age z‐score (dashed), and length‐for‐age
z‐score (solid). Grey shaded area represents 95% confidence interval
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but only 22% being exclusively breastfed through 6 months. Only
15% of the population relied on an open water source. On aver-
age, 36% of mothers reported that their infant had been ill since the
last visit.
Average LAZ was −0.48 at 6 weeks and declined steadily over
most of the study period, reaching −1.55 by 24 months (Figure 1).
Average WAZ decreased less rapidly than LAZ. At 6 weeks, mean
WAZ was −0.05 and declined slowly in a nearly linear trend to −0.51
at 24 months. As a result, average WLZ for the first observation was
0.67 and only declined to 0.41 by 24 months. At 24 months, four
(0.7%) infants were wasted, 24 (4.1%) were underweight, and 78
(13.4%) infants were stunted.FIGURE 2 Growth trajectories of infants from 6 to 24 months according
the largest number of infants at birth is Class 1. Grey shaded area represe
length‐for‐age z‐score3.2 | Latent class analysis
Figure 2 shows mean growth trajectories of each class for WLZ and
LAZ. Three of the four WLZ classes have z‐scores near 1 at 6 weeks
but quickly diverge. The outlying class, Class 4, has a lower initial
WLZ, which declines until about 9 months. This pattern is markedly
different from that of Class 1, which gains weight rapidly and main-
tains an average z‐score above 2 from 9 to 24 months.
Growth trajectories in LAZ are more variable than WLZ, resulting
in more classes. LAZ Classes 1 and 4 show little change in z‐score over
time. Classes 6 and 7 have z‐scores below −1 at 6 weeks and experi-
ence parallel declines before slight recoveries. Class 5 has an early,
average LAZ near 0, but z‐score rapidly declines, dropping below Class
4 and falling to −2.21 by 18 months. In contrast, Class 1 has a LAZ of
1.83 at 6 weeks and experiences only a slight decline to 0.98 by
24 months.
Class membership for WLZ and LAZ is correlated (P value: 0.04).
Infants in heavier WLZ classes also tend to be in taller LAZ classes;
infants that are large in terms of weight also tend to be large in terms
of height. However, there are 14 infants in the heaviest WLZ class and
an LAZ class (Class 5, 6, or 7) that became stunted.3.3 | Predictors of class membership
Male infants have an increased likelihood of being in the class that
develops the highest WLZ (Table 1). Infants with high neonatal WAZ
and firstborn infants are more likely to be in the second highest
WLZ class. Infants with low neonatal WAZ have an increased
likelihood of being in the lowest WLZ class and the two lowest LAZ
classes. Shorter mothers are more likely to have infants that experi-
ence linear growth faltering; however, females have taller mothers
than males in this class (Table 2).
Regardless of breastfeeding status, infants with a higher percent
of illness periods are more likely to be in the lowest WLZ class
(Table 1). Among female infants, delaying the end of exclusiveto latent class analysis. Classes are numbered such that the class with
nts 95% confidence interval. WLZ: weight‐for‐length z‐score; LAZ:
TABLE 1 Odds of weight‐for‐length z‐score class membership by infant characteristics and life events
Class 1 Class 2 Class 3 Class 4
Odds of class membership by infant characteristics
Sex −1.11 (−2.05, −0.18) −0.23 (−0.71, 0.24) Ref 0.1 (−0.38, 0.58)
Firstborn 0.89 (0.02, 1.75) 0.57 (0.06, 1.07) Ref −0.006 (−0.34, 0.70)
Maternal education 0.06 (−0.14, 0.25) 0.06 (−0.05, 0.16) Ref −0.006 (−0.12, 0.11)
Neonatal WAZ 0.22 (−0.12, 0.55) 0.35 (0.15, 0.55) Ref −0.21 (−0.40, −0.03)
Water source 0.04 (−1.27, 1.34) 0.48 (−0.16, 1.12) Ref −1.13 (−2.06, −0.20)
Maternal height 0.04 (−0.03, 0.11) 0.002 (−0.04, 0.04) Ref 0.009 (−0.03, 0.05)
Odds of class membership by infant life events
Sex −0.82 (−1.68, 0.04) −0.13 (−0.59, 0.33) Ref 0.18 (−0.10,0.12)
Maternal education 0.03 (−0.16, 0.21) 0.02 (−0.08, 0.44) Ref 0.01 (0.28, 2.70)
Proportion of visits ill −1.89 (−4.21, 0.44) −0.5 (−1.74, 0.74) Ref 1.49 (0.28, 2.70)
Intro. to compl. feeding 0.04 (−0.27, 0.35) 0.09 (−0.08, 0.26) Ref 0.05 (−0.12, 0.23)
Note. WAZ: weight‐for‐age z‐score.
Numbers in bold are P < 0.05.
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tallest LAZ class (Table 2).4 | DISCUSSION
4.1 | Mean growth trends
In the context of Option B+ and extended breastfeeding, these
HEU infants develop elevated weight‐for‐length, but linear growth
remained well below the WHO standard. In contrast, infants in low‐
and middle‐income countries worldwide tend to have roughly equiva-
lent decreases in weight and length for the first year of life relative to
the WHO standard (Victora, de Onis, Hallal, Blossner, & Shrimpton,
2010). This results in the average weight‐for‐length of infants in these
low‐resource environments being slightly below 0. After 1 year, in
low‐ and middle‐income contexts, linear growth decreases more than
ponderal growth and weight‐for‐length increases slightly. However,
study infants exhibited greater length than weight deficits from birth,
resulting in WLZ averaging about 0.5 standard deviations above the
WHO median. As such, we conclude that these HEU infants have
unique growth trajectories that are not observed in other infants in
resource‐restricted settings.
Compared with the Rwandan population, as represented in the
2015 Rwanda Demographic and Health Survey (DHS), these HEU
infants have lower early LAZ and elevated early WLZ; however, their
growth patterns converge towards the national means over time
(National Institute of Statistics, Ministry of Health, & ICF International,
2015). TheDHSmean LAZwas −0.7 at 6–8months and −1.8 by 18–23-
months. In the Kabeho sample, mean LAZwas −1.02 at 6–8months but
only declined to −1.66 by 18–23 months. The DHS meanWLZ was 0.3
at 6–8 months and remained the same at 18–23 months. MeanWLZ in
Kabeho infants was 0.63 at 6–8 months and declined to 0.38 at
18–23 months. These data show that HEU infants do not follow the
average growth trajectory of other infants in their geographic area.
Differences in growth between infants in the Kabeho Study and
the broader Rwandan population could, in theory, be related tocontinued lower rates of breastfeeding among HIV‐positive women
despite current recommendations. Rwandan mothers and women in
this study both engage in intensive and prolonged breastfeeding
(National Institute of Statistics, Ministry of Health, & ICF Interna-
tional, 2015). However, in Rwanda, exclusive breastfeeding occurs
for 5.4 months on average, but in Kabeho, exclusive breastfeeding
ends almost a month earlier on average. Among the broader Rwandan
population, any breastfeeding continues for more than 28 months on
average. In contrast, in the Kabeho Study, only 5% of infants were
still breastfed at 24 months. Nonetheless, studies in Malawi failed
to find an association between breastfeeding and infant WLZ
(Kamudoni, Maleta, Shi, & Holmboe‐Ottesen, 2015; Kuchenbecker
et al., 2015). In addition, in a randomized controlled trial in Kenya,
there was no difference in the risk of stunting, underweight, or
wasting between HEU infants who were breastfed or formula fed.
These results indicate that our findings may not be driven by differ-
ences in breastfeeding (McGarth et al., 2012). However, in Bhutan,
breastfeeding proved to be protective against infant overweight
status (Campbell, Kang, & West, 2017). Therefore, if breastfeeding
were to have an effect, it would likely be in the opposite direction
from what we observed.
The pattern of low early LAZ and elevated early WLZ relative to
unexposed infants in the same setting was not seen in studies that
occurred before the widespread availability of ART. In Ghana, infants
born to HIV‐positive women and treated with nevirapine had
consistently lower LAZ from birth to 12 months than infants born to
HIV‐negative women; however, there was no difference in WLZ by
HIV exposure status (Lartey et al., 2014). These infants did not have
the elevated WLZ observed in our population. In Zimbabwe before
the availability of ART, HEU infants had higher risk of stunting and
wasting, but growth trajectories in LAZ and WLZ were not meaning-
fully different from unexposed infants over the first 2 years of life
(Omoni et al., 2017). HEU infant WLZ was lower than unexposed
infants WLZ in this setting, whereas we find that HEU infant WLZ is
higher than the average WLZ of Rwanda as a whole. In Zimbabwe
case, both unexposed and HEU infants had slightly elevated WLZ at
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bs_bs_bannerof ART, mean LAZ, WAZ, and WLZ were all close to −1 by 24 months
in Kenya (McGarth et al., 2012). Under these conditions, formula feed-
ing was protective against slow growth. In Tanzania before the wide-
spread availability of ART but with nearly universal breastfeeding,
24‐month LAZ was nearly −2 and WLZ was below −1 (Webb, Manji,
Fawzi, & Villamor, 2009). As such, we conclude that this pattern of
low LAZ combined with elevated WLZ is unique to HEU infants in
the modern era of PMTCT practices.
The mean growth patterns observed in these HEU infants are
consistent with previous work in HEU infants exposed to ART. A
similar study in Malawi found high average BMI z‐score and
declining LAZ from 24 to 48 weeks (Flax et al., 2013). These infants
were part of an intervention study that counselled women to exclu-
sively breastfeed for 6 months, and in the majority of cases, either
the mother or the infant received ART. In a Zambian study in which
mothers received single dose nevirapine, average LAZ was below
−2.2 and WAZ was about −1.2, resulting in a higher average WLZ of
−0.1 by 21 months (Arpadi et al., 2009). WLZ and WAZ were signifi-
cantly higher in breastfed infants compared with infants that had
stopped breastfeeding from 4 to 15 months. In both of these studies,
the combination of ART and breastfeeding resulted in a higher WAZ
relative to LAZ and, therefore, much higher weight relative to height.
One study in Botswana among breastfed infants whose mothers
received either highly active ART or zidovudine found a different pat-
tern, with WAZ lower than LAZ and WLZ of approximately 0 (Powis
et al., 2011). However, this study was restricted to 0 to 6 months.
Together, these results show that breastfeeding and ART may increase
WLZ in HEU infants. Nonetheless, ART and breastfeeding are not
sufficient to promote a healthy LAZ among HEU infants.4.2 | Variation in growth trends
The considerable heterogeneity in growth patterns demonstrated in
our population through the latent class analysis highlights the
importance of our approach. Mean growth trends do not adequately
describe the actual variation in growth that occurs within this popula-
tion. Classes exhibit a variety of patterns with some LAZ classes barely
decreasing in z‐score, whereas others fall considerably. One WLZ class
has a large decrease in z‐score, whereas the others remain above 0
throughout the entire study period. In addition, the 14 infants in both
the highest WLZ class and the growth faltering LAZ classes show that
these growth trajectories can have unusual combinations and different
determinants may influence growth in both LAZ and WLZ.
To our knowledge, only one other paper has attempted to classify
and predict growth trajectories within infants in low‐income settings
(Gough et al., 2016). This paper examined growth in non‐HEU infants
in Zimbabwe using cluster analysis. Similar to our findings, authors
report that infants with greater birthweight, birth length, and taller
mothers were more likely to be in LAZ growth classes with healthier
trajectories. In addition, among these Zimbabwean infants, males were
more likely than females to be in the most growth‐restricted groups. In
our population, males were at increased odds of being in the class that
had normal weight near birth then experienced growth faltering. No
studies have examined patterns in WLZ trajectories.The likelihood of growth trajectory membership varied by infant
sex, neonatal WAZ, maternal height, percent illness periods, and age
at the end of exclusive breastfeeding. Males, infants with taller
mothers, or those with higher neonatal WAZ were more likely to grow
quickly in terms of relative weight. Similarly, one study of HEU infants
in Malawi found that BMI z‐score was positively associated with
maternal height, but not with infant sex (Flax et al., 2013). However,
another study, also in HIV‐exposed infants in Malawi, found that
males had higher WLZ than females, after adjusting for HIV status
(Taha et al., 2010). Maternal height was low in classes that became
stunted. This is consistent with previous work that found maternal
height to be associated with stunting in HEU infants (Flax et al.,
2013; McGarth et al., 2012).
Study infants with a higher percent of illness periods had
increased odds of being in the lowest WLZ class. Among HIV‐exposed
infants in Tanzania, an illness episode since the last measurement was
also associated with a decline in WLZ but not LAZ, independent of the
infant's HIV status (Webb et al., 2009). Among HEU infants in Kenya,
incidence of diarrhoea was associated with increased hazard of
wasting (McGarth et al., 2012). Additionally, among females, ending
exclusive breastfeeding at an older age was associated with an
increased likelihood of the second tallest LAZ class. Among study
infants, 81% of infants were exclusively breastfed between 3 and
4 months, and this may have been an important contributor to their
modest weight deficits at (WAZ = −0.16) at 4 months. Similarly, among
HIV‐exposed infants in Malawi, breastfeeding was associated with
higher LAZ and WLZ after controlling for infant HIV status
(Taha et al., 2010). However, in Zambia, the early cessation of
breastfeeding among HEU infants had little impact on LAZ but was
associated with a decrease in WLZ (Arpadi et al., 2009).4.3 | Limitations
There are several limitations to this study. Our sample size may be too
small to detect effects for certain classes with smaller numbers, and
many infants do not have data at all‐time points, making some analy-
ses less powerful. There was some loss to follow‐up, which could
result in biases estimates of growth values later in life. However,
infants who were subsequently lost had no difference in growth out-
comes from those who remained in the study. In addition, because
these are observational data, there can be no proof of causality from
this study. We do not have detailed dietary data on the amounts of
breast milk or complementary foods consumed. Nonetheless, this
research is a descriptive first step in understanding growth trajectories
in an HEU population. Future research should attempt to replicate
these findings in larger cohorts and may include longer follow‐up
periods. Also of interest are the infants in the highest WLZ class and
LAZ classes that experience stunting. This discordance between
WLZ and LAZ status is a rare opportunity to study factors that cause
high WLZ without a similar effect on LAZ. The long‐term health con-
sequences of this growth pattern could be of public health interest
as the elevated WLZ may serve to counteract some of the negative
impacts of low LAZ on health outcomes in this population.
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The vast majority of the literature on the relationship between early
growth and later health considers growth endpoints such as z‐scores
or stunting and wasting status at specific ages. Infant growth end-
points are related to a variety of future outcomes including school
attainment, productivity, cognitive development, wages, obesity, insu-
lin resistance, and blood pressure (Adair, 2014; Denneman et al., 2018;
Ribe, Svensen, Lyngmo, Mduma, & Hinderaker, 2018). However, there
has been little study of the effect of the path by which infants reach
their growth endpoints on future health. Our work shows that consid-
ering growth endpoints alone may not be sufficient due to the variety
of paths by which infants may reach their endpoints. For example, LAZ
Classes 4 and 5 have essentially the same mean z‐scores at 6 months
but show very different growth patterns thereafter. LAZ Classes 3 and
4 have similar z‐scores by 24 months, but Class 3 experienced a
decrease in mean z‐score of almost 1 SD whereas Class 4 had nearly
no change in z‐score. The path by which infants reach their endpoints
is likely to impact future health outcomes. In Europe, infants in growth
classes with rapid BMI increases in the first 2 years of life have higher
risk of developing asthma before age six (Rzehak et al., 2013). We
start the effort to relate growth trajectories to health outcomes by
characterizing heterogeneity in infant growth outcomes and identify-
ing some predictors of poor growth patterns. Future work should con-
sider heterogeneity in infant growth patterns and attempt to link these
patterns to health outcomes later in life.5 | CONCLUSION
From a public health standpoint, understanding the variability of
growth trajectories in a population allows for an understanding of
the variability in the health and well‐being of that population. Growth
can be viewed as either a determinant of future health or as a marker
of an underlying process that also determines adult outcomes (Dewey
& Begum, 2011). Regardless of whether growth is a determinant of
these outcomes or a metric of some other determinant, early develop-
ment is essential for adult achievement (Grantham‐McGregor et al.,
2007). Therefore, an understanding of the various trajectories by
which these infants grow allows us to understand the variability in
the health of these infants. We show that mean values do not ade-
quately describe the meaningful variations in growth patterns of this
population. We also show that many of the factors related to poor
growth endpoints in other populations put infants on developmental
tracks that affect health and well‐being throughout infancy and likely
into later life.
As the population of HEU infants increases in sub‐Saharan Africa,
it is becoming more important to take steps to ensure that these
infants achieve optimal growth so they can maximally contribute to
the economic and social development of their countries. Efforts
should be taken to support the health and well‐being of these infants
who experience increased risk of morbidity and mortality. The wide-
spread adoption of Option B+ and continued breastfeeding may be
able to improve growth outcomes for these infants. In our population
of HEU infants exposed to Option B+ and continued breastfeeding,infants have higher WLZ for the first 2 years of life and lower LAZ
for the first 6 months than infants in other low‐resource settings,
including Rwanda, but their growth converges towards that seen in
comparable populations. When compared with the Rwandan popula-
tion, these HEU infants had lower early LAZ and higher early WLZ.
However, these patterns are very heterogeneous. Future research
should investigate both potential causal pathways leading to this
unusual growth, slow linear growth and elevated weight, and the
long‐term health consequences of these early growth patterns.
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